Abstract

An agent that clears disease-associated amyloid aggregates from the brains of patients with Alzheimer's disease does not alleviate disease progression. Yet this disappointing news should not rule out such potential therapies.

Original languageEnglish
Pages (from-to)418-420
Number of pages3
JournalNature
Volume454
Issue number7203
DOIs
StatePublished - Jul 24 2008

Fingerprint

Dive into the research topics of 'Alzheimer's disease: Moving towards a vaccine'. Together they form a unique fingerprint.

Cite this